UY26085A1 - N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica - Google Patents
N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- UY26085A1 UY26085A1 UY26085A UY26085A UY26085A1 UY 26085 A1 UY26085 A1 UY 26085A1 UY 26085 A UY26085 A UY 26085A UY 26085 A UY26085 A UY 26085A UY 26085 A1 UY26085 A1 UY 26085A1
- Authority
- UY
- Uruguay
- Prior art keywords
- metanamina
- benzodioxina
- aminofenil
- dihidro
- therapeutics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos de fórmula general I.Aplicación en terapéutica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9903936A FR2791675B1 (fr) | 1999-03-30 | 1999-03-30 | Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26085A1 true UY26085A1 (es) | 2000-10-31 |
Family
ID=9543788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26085A UY26085A1 (es) | 1999-03-30 | 2000-03-29 | N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU3660700A (es) |
CO (1) | CO5170535A1 (es) |
FR (1) | FR2791675B1 (es) |
PE (1) | PE20001598A1 (es) |
UY (1) | UY26085A1 (es) |
WO (1) | WO2000058301A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0117396D0 (en) | 2001-07-17 | 2001-09-05 | Glaxo Group Ltd | Chemical compounds |
GB0308208D0 (en) | 2003-04-09 | 2003-05-14 | Glaxo Group Ltd | Chemical compounds |
WO2006089053A2 (en) | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
CA2605587A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
AU2006239930A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Benzodioxane and benzodioxolane derivatives and uses thereof |
AR060493A1 (es) * | 2006-04-18 | 2008-06-18 | Wyeth Corp | Derivados de benzodioxano y benzodioxolano. procesos de obtencion. |
CL2007003065A1 (es) * | 2006-10-24 | 2008-01-25 | Wyeth Corp | Compuestos derivados de benzodioxano, agonista 5ht2c, composicion farmaceutica que lois comprende; y sus uso en el tratamiento de un trastorno psicotico, ansiedad, depresion, trastorno bipolar, sindrome premenstrual, entre otros |
EP2271635A1 (en) * | 2008-04-29 | 2011-01-12 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | Modulators of dopamine neurotransmission |
AU2009242095A1 (en) | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
AU2009242092A1 (en) | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
GB201801128D0 (en) | 2018-01-24 | 2018-03-07 | Univ Oxford Innovation Ltd | Compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1054104A (es) * | 1962-07-20 | |||
CA1147342A (en) * | 1977-10-12 | 1983-05-31 | Kazuo Imai | Process of producing novel phenylethanolamine derivatives |
-
1999
- 1999-03-30 FR FR9903936A patent/FR2791675B1/fr not_active Expired - Fee Related
-
2000
- 2000-03-27 WO PCT/FR2000/000762 patent/WO2000058301A1/fr active Application Filing
- 2000-03-27 AU AU36607/00A patent/AU3660700A/en not_active Abandoned
- 2000-03-29 UY UY26085A patent/UY26085A1/es unknown
- 2000-03-29 CO CO00022433A patent/CO5170535A1/es not_active Application Discontinuation
- 2000-03-30 PE PE2000000275A patent/PE20001598A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20001598A1 (es) | 2001-04-01 |
FR2791675A1 (fr) | 2000-10-06 |
AU3660700A (en) | 2000-10-16 |
CO5170535A1 (es) | 2002-06-27 |
FR2791675B1 (fr) | 2001-05-04 |
WO2000058301A1 (fr) | 2000-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26082A1 (es) | Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica | |
BR0108396A (pt) | Derivados de pirimidina-4-0na como inibidores de ldl-pla(2) | |
PT1109812E (pt) | Pirrolobenzodiazepinas | |
ECSP056111A (es) | Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica | |
PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
PT1169460E (pt) | Preparacao de moleculas biologicamente activas. | |
DK0944643T3 (da) | Oxyiminopregnancarbolactoner. | |
EE200100370A (et) | Teraapias kasutatavad spirofuropüridiinide uued aralküülamiinid | |
SE0101387D0 (sv) | Novel compounds | |
BRPI0413022A (pt) | derivados de 3-amino cromado e 2-amino tetralina | |
UY25712A1 (es) | Benzamidas sustituidas y su aplicación en medicamentos | |
PT1230230E (pt) | Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico | |
MY133969A (en) | Indoloquinazolinones | |
UY26085A1 (es) | N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica | |
PT1242410E (pt) | Compostos novos | |
MY134026A (en) | ?-carboline derivatives and its pharmaceutical use against depression and anxiety | |
SE9802209D0 (sv) | Novel compounds | |
BR0316544A (pt) | Compostos calcilìticos | |
ITMI20000293A0 (it) | Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica | |
ATE213236T1 (de) | Substituierte benzyloxyimino-verbindungen | |
AR023374A1 (es) | Derivados de 3-amino-3-arilpropano-1-ol. su preparacion y uso | |
AR023895A1 (es) | Nuevos derivados de 6-amino-uracilo, su preparacion y su utilizacion | |
AR026890A1 (es) | Composiciones de tenocitos, preparaciones y utilizaciones | |
UY26102A1 (es) | Derivados de 1-aminoetilindol, su preparación y su aplicación en terapéutica | |
ES2183543T3 (es) | Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica. |